Autosomal Recessive Transmission of MYBPC3 Mutation Results in Malignant Phenotype of Hypertrophic Cardiomyopathy
Authors:
Open Access
- 28 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6) , e67087
Abstract
Hypertrophic cardiomyopathy (HCM) due to mutations in genes encoding sarcomere proteins is most commonly inherited as an autosomal dominant trait. Since nearly 50% of HCM cases occur in the absence of a family history, a recessive inheritance pattern may be involved. A pedigree was identified with suspected autosomal recessive transmission of HCM. Twenty-six HCM-related genes were comprehensively screened for mutations in the proband with targeted second generation sequencing, and the identified mutation was confirmed with bi-directional Sanger sequencing in all family members and 376 healthy controls. A novel missense mutation (c.1469G>T, p.Gly490Val) in exon 17 of MYBPC3 was identified. Two siblings with HCM were homozygous for this mutation, whereas other family members were either heterozygous or wild type. Clinical evaluation showed that both homozygotes manifested a typical HCM presentation, but none of others, including 5 adult heterozygous mutation carriers up to 71 years of age, had any clinical evidence of HCM. Our data identified a MYBPC3 mutation in HCM, which appeared autosomal recessively inherited in this family. The absence of a family history of clinical HCM may be due to not only a de novo mutation, but also recessive mutations that failed to produce a clinical phenotype in heterozygous family members. Therefore, consideration of recessive mutations leading to HCM is essential for risk stratification and genetic counseling.Keywords
This publication has 30 references indexed in Scilit:
- Double or compound sarcomere mutations in hypertrophic cardiomyopathy: A potential link to sudden death in the absence of conventional risk factorsHeart Rhythm, 2012
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive SummaryCirculation, 2011
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Worse Prognosis with Gene Mutations of Beta‐myosin Heavy Chain than Myosin‐Binding Protein C in Chinese Patients with Hypertrophic CardiomyopathyClinical Cardiology, 2008
- Clustal W and Clustal X version 2.0Bioinformatics, 2007
- Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the AmishHeart, 2007
- Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counsellingJournal of Medical Genetics, 2005
- Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathyJACC, 2004
- Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic CardiomyopathyNew England Journal of Medicine, 1998
- Cardiac myosin binding protein–C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathyNature Genetics, 1995